October 12th 2025
This issue showcases strategies that organizations are adopting to stay competitive as pressing industry trends shape the sector.
NIH Study Shows Antidepressants May Enhance Drug Delivery to Brain
April 27th 2017A new study from the United States National Institutes of Health (NIH) found that pairing the antidepressant amitriptyline with drugs designed to treat central nervous system diseases, enhances drug delivery to the brain by inhibiting the blood-brain barrier in rats. The blood-brain barrier serves as a natural, protective boundary, preventing most drugs from entering the brain. The research, performed in rats, appeared online April 27, 2017 in the Journal of Cerebral Blood Flow and Metabolism.
Sandoz’s Rituximab and Etanercept Biosimilars Recommended for European Approval
April 24th 2017Sandoz, a Novartis division, announced that the Committee for Medicinal Products for Human Use (CHMP) has adopted positive opinions recommending the approval of its biosimilars rituximab and etanercept in Europe, for the same indications as the respective reference medicines.